Asia Fresh News

Asia Fresh Stories

Archive for April 18th, 2012

MDT Releases TMR Magnetic Angle Sensors for Rotary Encoders

leave a comment »

TMR Sensor Technology Enhances New Magnetic Angle Sensors with High Precision and Robust Signal Output for Industrial Rotary Encoders and BLDC Controllers

SAN JOSE, Calif. and ZHANGJIAGANG, Jiangsu, China, April 17, 2012 /PRNewswire-Asia/ — MultiDimension Technology( ) Co., Ltd. (MDT) announced two Tunneling Magnetoresistance (TMR) magnetic angle sensors for use in a wide spectrum of industrial sensor applications, including rotary encoders, speed sensors, contactless potentiometers, and rotary position controllers for brushless DC motors (BLDC).

To view the multimedia assets associated with this release, please click:

(Photo: )
(Logo: )

Designed with MDT’s unique TMR sensor technology and intellectual property, the MMA253F/MMA153F TMR magnetic angle sensors feature 360-degree angle measurement, high-amplitude robust output signals, and large air-gap tolerance. MDT’s TMR magnetic angle sensors lower the complexity of the signal processing circuitry.

“We are passionate about offering all the benefits of TMR sensor technology to our customers with multiple service options to best suit their needs,” said Dr. Song Xue, Chairman and CEO of MultiDimension Technology. “In addition to supplying TMR magnetic sensor chips, we are open to delivering entire system solutions upon request. We can custom-design TMR sensor wafers for high-volume customers to integrate with their own ASIC technology.”

Dr. Xue noted that MDT’s new TMR magnetic angle sensors reduce the overall system cost of rotary encoders because of their lower power, high precision, and large stable output signals. They provide a simple solution to integrate with analog or digital circuitry.

MDT’s TMR sensor technology combines the key benefits of existing magnetic sensor technologies such as AMR (Anisotropic Magnetoresistance), GMR (Giant Magnetoresistance), and Hall Effect, while overcoming their limitations, such as low signal sensitivity (Hall, AMR, and GMR), and design complexity for 360-degree measurement (AMR).

Key Features

— 360-degree measurement with dual-axis SINE/COSINE outputs (MMA253F)
— Single-axis 180-degree measurement (MMA153F)
— Large output signal above 90 percent of supply voltage,
eliminating the need for amplification
— Very-low power consumption at 7 microamperes under 1V supply
— High precision (1-degree angular position error) and fine
resolution (12-bit with custom circuitry)
— Large air-gap tolerance permitting greater versatility and choice
of implementations
— Small LGA8 or SOP8 package

The MMA253F/MMA153F TMR magnetic sensors are immediately available for sampling. An evaluation toolkit, the MMA253F-EVL, is also available for users to assess the electrical and magnetic characteristics of the MMA253F sensor. The MMA253F-EVL toolkit provides an LCD display, a USB interface, and 12-bit digital outputs that can be used in absolute or incremental rotary encoders.

About MDT

MultiDimension Technology was founded in 2010 in Zhangjiagang, Jiangsu Province, China, with branch offices in Shanghai and San Jose, Calif., USA. MDT has developed a unique intellectual property portfolio, and state-of-the-art manufacturing capabilities that can support volume production of high-performance, low-cost TMR magnetic sensors to satisfy the most demanding application needs. Led by its core management team of elite experts and veterans in magnetic sensor technology and engineering services, MDT is committed to creating added value for its customers and ensuring their success. For more information about MDT please visit

Media Contact
Jinfeng Liu,, Tel: +1-650-275-2318 (US), +86-189-3612-1156 (China)

SOURCE﹛MultiDimension Technology Co., Ltd.

Written by asiafreshnews

April 18, 2012 at 11:51 am

Posted in Uncategorized

Thai Broker KT ZMICO Securities Goes Live with SunGard’s Valdi for Market Making

leave a comment »

BANGKOK, April 17, 2012 /PRNewswire-Asia/ — KT ZMICO Securities( ), a leading Thai brokerage firm, is live with SunGard’s Valdi( ) trading, connectivity and market making solution suite to help automate and streamline its trading activities into one integrated trading screen on the Stock Exchange of Thailand (SET). Valdi also helps KT ZMICO better manage its exposure by providing a consolidated view of positions and the ability to hedge in real-time.
KT ZMICO selected SunGard’s Valdi trading and connectivity suite to deal electronically, help reduce operational risk and collect orders from various sources, including the SunGard Global Network( ), an order routing network. KT ZMICO is also using Valdi to help automate its trading strategies and quoting capabilities on the local warrants marketplace.

Chaipatr Srivisarvacha, the executive chairman and chief executive officer of KT ZMICO Securities, said, “KT ZMICO can electronically issue its derivatives warrants on the SET and automate its trading business with SunGard’s Valdi suite, thus helping bring more liquidity to the exchange. This is a major breakthrough for the SET because many international investors still consider it to be an emerging market. SunGard can help us bring innovation to the Thai financial industry and assist us in generating more revenue.”

Nasser Khodri, South East Asia managing director of SunGard’s capital markets business, said, “The SET has launched many initiatives to increase its volumes, including support for local market makers and facilitating trading by international investors through the ASEAN Trading Link( ). SunGard’s Valdi solutions are helping brokers in frontier and emerging markets like Thailand bring liquidity to regional exchanges, facilitate automated trading strategies, reduce operational risk and support business development.”

About KT ZMICO Securities

KT ZMICO Securities Company Limited is one of leading investment service provider in Thailand, under the establishment of a joint venture between Krung Thai Bank Public Company Limited (KTB) and Seamico Securities Public Company Limited (SEAMICO). KT ZMICO provides wide range of investment products and services such as securities trading service, derivatives, derivatives warrants (DW), bond and debenture, securities borrowing and lending (SBL), investment banking, wealth management & private fund, also including international markets investment service i.e. trading in the stock exchange market in America, Hong Kong, Singapore, and countries in Indochina region. For more information, visit

About SunGard’s Valdi

SunGard’s Valdi provides equities, futures, fixed income and options traders with multi-asset trading solutions on 170+ markets worldwide. Valdi global trading solutions support the entire trade lifecycle, including integrated trade and order management systems, execution services, market data, risk management, compliance, and clearing and settlement services. Also offering global connectivity via the SunGard Global Network (SGN), SunGard’s Valdi helps customers achieve increased performance and low latency execution across multiple platforms, instruments and geographies.

About SunGard

SunGard is one of the world’s leading software and technology services companies. SunGard has more than 17,000 employees and serves approximately 25,000 customers in more than 70 countries. SunGard provides software and processing solutions for financial services, education and the public sector. SunGard also provides disaster recovery services, managed IT services, information availability consulting services and business continuity management software. With annual revenue of about $4.5 billion, SunGard is the largest privately held software and services company and was ranked 434 on the Fortune 500 in 2011. Look for us wherever the mission is critical. For more information, please visit


Written by asiafreshnews

April 18, 2012 at 11:45 am

Posted in Uncategorized

Automation to Push Molecular Diagnostics Markets to New Level, Avers Frost & Sullivan

leave a comment »

Companies to Collaborate and Leverage on Respective Research and Marketing Strengths
LONDON, April 17, 2012 /PRNewswire-Asia/ — The potential for enhanced clinical efficiency and reduced costs is fuelling the interest of healthcare stakeholders in preventive medicine. Molecular diagnostics is a vital tool to support this trend. Available molecular diagnostics technologies can detect diseases at very early stages and help monitor the efficacy of therapies being used in disease treatment.

New analysis from Frost & Sullivan ( )), European Molecular Diagnostics Market,finds that the marketearned revenues of $792.3 million in 2010 and estimates this to reach $1,494.4 million in 2015. The research covers oncology, genetic diseases, infectious diseases and pharmacogenomics segments.

“Technology advances, paralleled by the decreasing cost of automated systems, will boost market prospects,” notes Frost & Sullivan Industry Analyst Dominika Grzywinska. “Automation, in particular, will play an increasingly important role in market expansion.”

Many molecular diagnostic methods were historically based on steps of manual pipetting. Automated devices are nowadays replacing them and offer numerous advantages. These include faster turn-around time (TAT), manipulation of smaller volumes of liquids as well as more accurate and quantifiable results, compared to manual methods.

“Automation is currently of interest mostly among large diagnostic laboratories, but it is expected that, over time, automated systems will also be available at smaller laboratories,” remarks Grzywinska. “In small and medium-sized laboratories, if automation is implemented at all, it is likely to be based on single function automated devices rather than fully automated, comprehensive systems.”

However, automation of molecular diagnostics is still considered to be insufficient. This is especially the case in sample preparation and nucleic acid extraction, where the majority of work is performed manually. This leads to prolonged TAT, which is a challenge, especially when immediate results are required.

A key challenge will be to translate research into proven clinical outcomes. Proof of clinical validity is required when clinical claims are made. Proving clinical validity is also often a requirement for reimbursement of a particular test. However, obtaining such clinical proof is an expensive, lengthy and complex process.

“Partnerships between test developers and companies specialised in marketing of such tests are a good solution to translate innovations into clinically applicable solutions,” advises Grzywinska. “Small molecular diagnostics companies do not always have sufficient resources to both develop and then market new tests.”

Already, the market is witnessing the emergence of several small market participants, often focused on one segment or even delivering one or a couple of products. These companies are often spin-offs from research institutes or universities. As they often lack the capital for further growth, there is the strong likelihood that they will partner with other companies to successfully market their products.

If you are interested in more information on this study, please send an e-mail with your contact details to Janique Morvan, Corporate Communications, at

European Molecular Diagnostics Markets is part of the Clinical Diagnostics Growth Partnership Services programme, which also includes research in the following markets: European HIV/AIDS and Hepatitis B/C Molecular Diagnostics Market, The Emerging European Molecular POC Testing Markets and U.S. Inherited Disease Molecular Diagnostics Markets. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company’s Growth Partnership Service provides the CEO and the CEO’s Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit

European Molecular Diagnostics Markets

Janique Morvan
Corporate Communications — Europe
P: +33(0)1-42-81-20-37
M: +33(0)6-79-22-41-42

SOURCE: Frost & Sullivan

Written by asiafreshnews

April 18, 2012 at 11:28 am

Posted in Uncategorized

CSL Behring Renews Pledge to Provide Significant Funding and Donated Coagulation Factor to World Federation of Hemophilia Over 3-Year Period

leave a comment »

Commitment will help WFH’s “Close the Gap” campaign aimed at improving healthcare in developing world
KING OF PRUSSIA, Pa. and MONTREAL, April 17, 2012 /PRNewswire-Asia/ — To mark World Hemophilia Day 2012, CSL Behring( ) has again committed to making significant financial contributions and donations of clotting factor concentrate to the World Federation of Hemophilia (WFH) Global Alliance for Progress (GAP) program over the period of three years, beginning in 2012. The product donations will be made with medicine having a minimum shelf-life of one year. The goal of the WFH GAP program is to improve the diagnosis and treatment of hemophilia in developing countries. In 2009, CSL Behring was the first company to make such a three-year commitment to WFH. CSL Limited, parent company to CSL Behring, is committed to contributing to the economic, social and environmental well-being of its communities. As part of the agreement, CSL Behring will provide 2 million units of one or more of its various clotting factor products to the WFH each year for three years.

“CSL Behring is proud to be a strong supporter of the World Federation of Hemophilia and to have been a contributor to the GAP program each year since it was established,” said Paul Perreault, President of CSL Behring. “We are committed to serving people who have rare and serious bleeding disorders and we will continue to work toward solutions that make a positive impact for hemophilia patients and their communities in regions of the world where those solutions are needed most.”

Blood clotting factor is manufactured from purified human plasma or by using recombinant technology.

CSL Behring clotting factor is manufactured in: the Kankakee, IL, USA facility of CSL Behring; in Melbourne, Australia, at the company’s Broadmeadows facility, and in Marburg, Germany.

“The product donations we receive from CSL Behring help us to support hemophilia patients in many remote areas of the world where access to these life-saving medicines is extremely challenging,” said Mark Skinner, president of WFH. “The reality is that most people with hemophilia or other bleeding disorder do not receive adequate diagnosis, treatment, and management for their conditions. WFH is committed to realizing a day when treatment and sustainable systems to deliver it are available globally in order to close the gap of care for these patients around the world. We certainly appreciate this kind of long-term commitment from CSL Behring. It helps us immeasurably toward that goal.”

An estimated one in one thousand women and men has a bleeding disorder.

About the Global Alliance for Progress

The Global Alliance for Progress (GAP) is a 10-year healthcare development project, launched in 2003. GAP’s goal is to greatly increase the diagnosis and treatment of people with hemophilia and other bleeding disorders in developing countries. The project aims to close the gap between the number of people born with hemophilia and those who reach adulthood, the gap between the estimated and actual number of people diagnosed with hemophilia, and the gap between the amount of treatment product needed versus what is available. To-date, a total of 23,324 patients with hemophilia, 2,423 with von Willebrand disease (VWD) and 1,509 with rare clotting factor deficiencies have been diagnosed/registered through the GAP program.

GAP partners include CSL Behring, the Jan Willem Andre de la Porte Family Foundation, the Irish Hemophilia Society, the World Health Organization (WHO) and other interested parties. GAP country programs are designed to improve five main areas: government support, the care delivery system, medical expertise and diagnosis, quality and quantity of treatment products, and the national hemophilia organization. At present, there are 12 ongoing GAP countries, including Algeria, Belarus, Ecuador, Lebanon, Moldova, Morocco, Peru, South Africa, Thailand, Tunisia, China, and Syria. Previous GAP countries included Armenia, Azerbaijan, Egypt, Georgia, Jordan, Mexico, the Philippines, and Russia.

About the World Federation of Hemophilia (WFH)

For 50 years, the World Federation of Hemophilia, an international not-for-profit organization has worked to improve the lives of people with hemophilia and other inherited bleeding disorders. Established in 1963, it is a global network of patient organizations in 118 countries and has official recognition from the World Health Organization. Visit WFH online at

About CSL Behring

CSL Behring is a global leader in the plasma protein biotherapeutics industry. Passionate about improving the quality of patients’ lives, CSL Behring manufactures and markets a range of safe and effective plasma-derived and recombinant products and related services. The company’s therapies are used in the treatment of immune deficiency disorders, hereditary angioedema, haemophilia, von Willebrand disease, other bleeding disorders and inherited emphysema. Other products are used for the prevention of hemolytic diseases in the newborn, in cardiac surgery, organ transplantation and in the treatment of burns. The company also operates one of the world’s largest plasma collection networks, CSL Plasma. CSL Behring is a subsidiary of CSL Limited, a biopharmaceutical company with headquarters in Melbourne, Australia. For more information, visit


Written by asiafreshnews

April 18, 2012 at 11:17 am

Posted in Uncategorized

Frost & Sullivan: Understanding Social Media Strategies Impacting Today’s Contact Centers

leave a comment »

Frost & Sullivan white paper identifies how social media can influence customer care

MOUNTAIN VIEW, Calif., April 17, 2012 /PRNewswire-Asia/ — Social media is currently generating considerable buzz within the contact center space as a new and very different communication channel. However, most firms are still trying to figure out how best to interact with customers via this medium. Critical themes to consider for social media deployment include: enabling social media in customer care, deploying home agents, complying with stringent security requirements, and providing private cloud functionality.

Frost & Sullivan( ) recently published a white paper, Enabling Successful Social Media Customer Care, which examines challenges, opportunities and how best to use social media to monitor and take action within the contact center.

Social media is fundamentally different from all other customer engagement channels in that it transmits public conversations. In the contact center context, social media becomes a customer collaboration tool for monitoring conversations and interacting publicly with consumers. As these lines of communication are opened, there are challenges in supporting social media that need to be addressed. This includes anonymity, maintaining security for sensitive information, and having agents with social media skills.

To be successful with social media, firms should consider creating a single department responsible for customer engagement strategy across all media. Ongoing participation by other departments is also encouraged to get employees on the same page, while also establishing a formal social media workflow.

“Public conversations follow a unique set of engagement rules,” said Frost & Sullivan Principal Analyst Michael DeSalles. “It is critical to capture the audience’s attention, ensure accuracy and promote and protect the brand.”

There are several key opportunities for improving customer interaction and relationship building. By engaging with customers using social media, contact centers can generate business development, detect early warnings of issues, and push for efficient communications between marketing and the customer base.

This white paper also addresses the need to select the right mix of strategies and tactics to successfully engage with customers over this new channel. In the search for a systems integrator, Strategic Products and Services (SPS) offers clients a full suite of solutions to improve operational efficiencies and lower cost; leveraging seasoned professionals and proven processes to uncover better ways to serve customers.

“A successful social media strategy requires a cross functional team with a deep understanding of customer behavior, social media tools and well-defined goals to achieve the highest results,” said Director, Contact Center Consulting Practice Strategic Products and Services, Monica Tarr. “Strategic Products and Services’ consultants are specialists at applying a holistic methodology when helping customers achieve results.”

Please click here( ) if you are interested in receiving a copy of the Enabling Successful Social Media Customer Care white paper.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company’s Growth Partnership Service provides the CEO and the CEO’s Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit

Media Contact:
Mireya Espinoza
Corporate Communications – North America
P: 210.247.3870
F: 210.348.1003 )
SOURCE: Frost & Sullivan

Written by asiafreshnews

April 18, 2012 at 10:36 am

Posted in Uncategorized